N/A
Manufactured by The Procter & Gamble Manufacturing Company
45 FDA adverse event reports analyzed
Last updated: 2026-04-15
ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by The Procter & Gamble Manufacturing Company. The most commonly reported adverse reactions for ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY include MOVEMENT DISORDER, CHEMICAL INJURY, IMPAIRED WORK ABILITY, SECRETION DISCHARGE, SKIN LESION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY.
Out of 5 classified reports for ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 45 FDA FAERS reports that mention ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include MOVEMENT DISORDER, CHEMICAL INJURY, IMPAIRED WORK ABILITY, SECRETION DISCHARGE, SKIN LESION, WOUND. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list The Procter & Gamble Manufacturing Company in connection with ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY. Always verify the specific product and NDC with your pharmacist.